Choose the right Container Closure Integrity Testing (CCIT) strategy with confidence. This Pace Life Sciences webinar explores deterministic and probabilistic test methods, including vacuum decay, HVLD, helium leak detection, and dye ingress. Learn a practical, risk-based framework for selecting the best CCIT approach based on package design, product characteristics, lifecycle stage, and regulatory expectations. Click here to learn more.
We aren't just a CDMO for standard antibodies, we also specialize in taking on the complex molecules (bispecifics, trispecifics, FC-fusions, and more).
Bringing complex therapies to market requires seamless integration across development, manufacturing, and regulatory strategy to reduce risk, speed timelines, and ensure quality.
Fluorescent mRNA reporters enable rapid visual confirmation of delivery and expression in mammalian cells, with bright signal, transient expression, and quantitative readouts.
An integrated manufacturing setup with microbial and mammalian lines, strong segregation and contamination control, plus end‑to‑end support to streamline biologics development.
Global partner delivering end‑to‑end drug development, manufacturing, and packaging with deep expertise, advanced facilities, and support across key modalities.
Optimized vector designs significantly enhance CHO cell protein expression, yielding higher titers, better stability, and strong performance across diverse host lines and scale‑up stages.
A unified global model streamlines biologics from discovery to commercial supply, integrating development, manufacturing, advanced modalities, and flexible partnerships worldwide.
Integrated culture and fermentation systems streamline development, improve scalability, and strengthen continuity throughout the lifecycle of complex biopharmaceutical programs.
With proven expertise in process development, optimization, and CGMP manufacturing, Avid offers end-to-end CDMO solutions backed by flexible capacity designed to scale with program needs.
With decades of experience, we’ve helped develop and commercialize multiple particle engineering-based drug delivery platforms and supported the development and commercialization of many enhanced drug products.
